THE FREQUENCY OF DIFFERENT CAUSES OF PREDOMINANT MOTOR NEUROPATHY IN PATIENTS PRESENTING AT TERTIARY CARE HOSPITAL

W KUMARI; T DAS; A DAS; JS RANA; M LAKHAIR; M IRFAN

doi:10.54112/bcsrj.v2024i1.1014

Authors

W KUMARI Department of Neurology, Dow University of Health Sciences/Civil Hospital Karachi, Pakistan
T DAS Department of Neurology, United Medical and Dental College/Creek General Hospital Karachi, Pakistan
A DAS Department of Neurology, Pir Abdul Qadir Shah Jilani Institue of Medical Sciences/Gambat Medical College, Pakistan
JS RANA Department of Neurology Dow University of Health Sciences Karachi, Sindh, Pakistan
M LAKHAIR Department of Neurology, Dow University of Health Sciences/Civil Hospital Karachi, Pakistan
M IRFAN Department of Neurology Dow University of Health Sciences Karachi, Sindh, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1014

Keywords:

Acute Motor Axonal Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, Cross-Sectional Studies, Neuropathy, Motor, Polyneuropathies, Predominant Motor Neuropathy, Tertiary Care Centers.

Abstract

Predominant motor neuropathy (PMN) encompasses a variety of neuropathies primarily affecting motor nerves, leading to muscle weakness and functional impairment. Identifying the causes of PMN is crucial for diagnosis and treatment planning. Objective: The present study aims to determine the frequency of different causes of predominant motor neuropathy in patients at a tertiary care hospital. Methods: This cross-sectional study was conducted at the Department of Neurology, Civil Hospital Karachi, from March 27, 2022, to September 27, 2022, following ethical approval from the institutional review board. A total of 139 patients aged 15-70 years, of either sex, diagnosed with PMN were included through non-probability consecutive sampling. Patients with predominant sensory neuropathy or mixed neuropathies were excluded. Data were analyzed using statistical methods to determine the frequency of various causes of PMN, with particular attention to gender and diabetes status. Results: The most frequent cause of neuropathy was Acute Motor Axonal Neuropathy (AMAN) (26.6%), followed by Acute Inflammatory Demyelinating Polyneuropathy (AIDP) (21.58%), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (19.4%), and Charcot-Marie-Tooth disease (16.5%). Less common causes included multifocal motor neuropathy (8.6%), porphyria (3.6%), lead intoxication (2.88%), and familial amyloid neuropathy type 2 (0.7%). There were significant differences in the frequency of neuropathy causes based on gender (p = 0.011) and diabetes status (p = 0.006). Conclusion: The study identified Acute Motor Axonal Neuropathy as the most frequent cause of predominant motor neuropathy, followed by Acute Inflammatory Demyelinating Polyneuropathy. These findings underscore the importance of recognizing specific causes of PMN for appropriate management.

Downloads

Download data is not yet available.

References

Tokuçoğlu F, Diniz G. Peripheral Neuropathies. Clues for Differential Diagnosis of Neuromuscular Disorders: Springer; 2023. p. 125-68.

Lehmann HC, Wunderlich G, Fink GR, Sommer C. Diagnosis of peripheral neuropathy. Neurological research and practice. 2020;2:1-7.

Cutellè C, De Lorenzo A, Doneddu PE, Creta MF, Selmi C, Liberatore G, et al. Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review. Journal of the Peripheral Nervous System. 2024.

Quiroz-Aldave J, Durand-Vásquez M, Gamarra-Osorio E, Suárez-Rojas J, Roseboom PJ, Alcalá-Mendoza R, et al. Diabetic neuropathy: Past, present, and future. Caspian journal of internal medicine. 2023;14(2):153.

Neal J, Gasque P. The role of primary infection of Schwann cells in the aetiology of infective inflammatory neuropathies. Journal of Infection. 2016;73(5):402-18.

Tran H, Smith DI, Chen E. Infectious Neuropathies. Pathogenesis of Neuropathic Pain: Diagnosis and Treatment: Springer; 2022. p. 249-80.

Yeh WZ, Dyck PJ, Van Den Berg LH, Kiernan MC, Taylor BV. Multifocal motor neuropathy: controversies and priorities. Journal of Neurology, Neurosurgery & Psychiatry. 2020;91(2):140-8.

Latov N. Immune mechanisms, the role of complement, and related therapies in autoimmune neuropathies. Expert Review of Clinical Immunology. 2021;17(12):1269-81.

Simmons Z, Albers JW, Bromberg MB, Feldman EL. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology. 1993;43(11):2202-.

Meuth SG, Kleinschnitz C. Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options. European neurology. 2010;63(4):193-204.

Jeong NY, Shin YH, Jung J. Neuropathic pain in hereditary peripheral neuropathy. Journal of exercise rehabilitation. 2013;9(4):397.

Vinik AI, Nevoret M-L, Casellini C, Parson H. Diabetic neuropathy. Endocrinology and metabolism clinics. 2013;42(4):747-87.

Baxi H, Habib A, Hussain MS, Hussain S, Dubey K. Prevalence of peripheral neuropathy and associated pain in patients with diabetes mellitus: Evidence from a cross-sectional study. Journal of Diabetes & Metabolic Disorders. 2020;19:1011-7.

Ekabe CJ, Kehbila J, Abanda MH, Kadia BM, Sama C-B, Monekosso GL. Vitamin B12 deficiency neuropathy; a rare diagnosis in young adults: a case report. BMC research notes. 2017;10:1-4.

Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. Continuum: Lifelong Learning in Neurology. 2014;20(5):1293-306.